XETRA - Delayed Quote EUR
Bristol-Myers Squibb Company (BRM.DE)
43.44
-0.28
(-0.65%)
At close: June 13 at 5:35:57 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
14,310,000
15,190,000
13,860,000
13,066,000
16,207,000
Investing Cash Flow
-2,233,000
-21,352,000
-2,295,000
-1,062,000
-538,000
Financing Cash Flow
-10,510,000
5,127,000
-9,416,000
-16,962,000
-16,224,000
End Cash Position
10,901,000
10,347,000
11,519,000
9,325,000
14,316,000
Capital Expenditure
-1,224,000
-1,248,000
-1,209,000
-1,118,000
-973,000
Issuance of Debt
384,000
15,969,000
4,455,000
6,120,000
0
Repayment of Debt
--
-5,873,000
-3,999,000
-11,431,000
-6,022,000
Repurchase of Capital Stock
--
0
-5,155,000
-8,001,000
-6,287,000
Free Cash Flow
13,086,000
13,942,000
12,651,000
11,948,000
15,234,000
12/31/2021 - 5/14/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDP.DE Biogen Inc.
113.80
-1.26%
GIS.DE Gilead Sciences, Inc.
95.24
+0.12%
GS71.DE GSK plc
17.89
-2.27%
4AB.DE AbbVie Inc.
167.00
+0.48%
SNW.DE Sanofi
86.95
-0.91%
AMG.DE Amgen Inc.
257.50
+0.63%
JNJ.DE Johnson & Johnson
136.02
+0.96%
ZEG.DE AstraZeneca PLC
129.35
-0.46%
6MK.DE Merck & Co., Inc.
70.50
0.00%
AZNl.XC